Company
Cullinan Therapeutics, Inc. (CGEM)
Standardized SEC financial data for Cullinan Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001789972 · NASDAQ · Biological Products, (No Diagnostic Substances).
Revenue growth (YoY)
-100.0%
Return on equity
-53.8%
Free cash flow
-$175.8M
Current ratio
10.25×
EPS (diluted)
$-3.69
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $18.9M | $0 | — | — | — |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $168.2M | $59.8M | $156.2M | $98.4M | $399.0M | $377.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$29.8M | -$43.4M | -$126.7M | -$134.3M | -$145.3M | -$175.8M |
| Capital expenditures |
Get CGEM data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CGEM/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CGEM/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"